Back to Newsroom

PTC Therapeutics Announces R&D Day to Review Multiple Orphan Disorder Programs

SOUTH PLAINFIELD, N.J., April 9, 2018 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that it will hold its R&D Day on Tuesday, April 17, 2018 from 12:00 p.m. to 5:00 p.m. ET in New York City. Members of PTC’s senior management and research teams will provide a corporate update and in-depth reviews of the Company’s commercial products, scientific platforms and R&D programs. In addition, a panel of external opinion leaders will share their insights in rare disorders including Duchenne muscular dystrophy, Spinal muscular atrophy and oncology.
READ MORE…